Now Erika Levi talking about an study of immediate postpartum contraceptive implant placement and breastfeeding outcomes. #SFP2022
The study was a single arm non inferiority design. Inclusion criteria:
- Desire for implant
- >14 years old
- Live birth >24w
- English or Spanish speaking
The primary measure was "Has your milk come in?"
Primary lactation failure define as a patient who answered the primary measure NO for 5 days postpartum.
50% who declined participation did so because they had strong opinions about when they got their implant and did NOT want to be randomized and possibly not receive the implant prior to hospital discharge.
The study controlled for risk factors for low milk supply including
- Diabetes
- Obesity
- Gestational age at delivery / Premature delivery
- PCOS
- History of difficulty with milk supply
CONCLUSIONS:
- The primary time to lactogenesis was 68 hours.
- There were 6 primary lactation failures
- There was NO difference between lactogenesis between groups
- Participants were very satisfied with the implant across study groups #SFP2022
This study came out of competing hospital goals: achieving #BabyFriendly hospital status and implementing access to immediate postpartum LARC. There was conflict between #IBCLC groups and #FamilyPlanning about the earlier mixed data on Nexplanon + lactogenesis
Audience: Is it ethical to randomize someone to a delayed LARC placement?
Dr. Ralph: Excellent point, which is why the study was transparent & why people for whom outpatient Nexplanon was perceived as high risk declined to participate (& got a LARC prior to discharge)
I am so impressed that there are several lactation consultants in the audience and attending SFP. I learned so much at #ABM2022 this year and hope for more collaboration between @BFMedicine and @SocietyFP in the future!
Where you train is where you work. Half of physicians stay in the states where they do their residency, so there is unlikely to be spontaneous sharing of abortion knowledge across communities. Healthcare inequities will continue to rise.
While this panel will focus on medical specialities, including OBGYNS and FM residents who are some of the most diverse subspecialties, there are so many trainees impacted by abortion restrictions including @ACNMmidwives and @GeneticCouns not to mention Pediatric and EM
Mifepristone approval/access has grown in so many ways:
- Globally access improved
- Indications for use expanded
- Methods of delivery expanding (telemedicine, meds by mail)
In Europe, Germany had the lowest uptake of medication abortion. This might be due to low reimbursement for simple and safe care in Germany and medication abortion is so safe!
Speaker Alejandra Pablos shares her story #KeepAleFree and encourages others to do so too through @AbortionStories. She says her story of fighting deportation, being detained and says that fighting for abortion rights are an intuitive extension of her goals and values.
Dr. Perritt @Reprorightsdoc encourages the audience to center on their own positionality. We focus on disclosures in medicine, but positionality - where we grew up, who we are, how the world sees us - are probably more important in framing our actions.
Speakers are from @PPFA where they lead the strategy and content that aims to to increase inclusivity and culturally appropriate care among Spanish speaking populations
They recognize that this is a HUGE task because of the immense diversity among Latinx populations. However, they report that language can be unifying across these cultural differences.